A detailed history of Rothschild Investment LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 95 shares of HALO stock, worth $4,655. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95
Previous 40 137.5%
Holding current value
$4,655
Previous $2.09 Million 159.69%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$51.3 - $64.42 $2,821 - $3,543
55 Added 137.5%
95 $5.44 Million
Q2 2024

Jul 30, 2024

BUY
$37.81 - $52.4 $1,512 - $2,096
40 New
40 $2.09 Million
Q1 2024

Jul 31, 2024

SELL
$33.68 - $41.95 $1,010 - $1,258
-30 Reduced 75.0%
10 $407,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.83B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.